Clinical trial
SARS-CoV-2 Infection in Patients With Hematological Malignancies: the Italian Hematology Alliance
NCT04352556 is registered in ClinicalTrials.gov with Ospedale di Circolo - Fondazione Macchi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SARS-CoV-2 Infection in Patients With Hematological Malignancies: the Italian Hematology Alliance
- Lead sponsor
- Ospedale di Circolo - Fondazione Macchi
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 7, 2020
- Completion date
- October 1, 2022
- Enrollment
- 250 (estimated)
- Sites
- 81
Conditions
As the registry lists them; a condition with its own page is linked.
hematological malignancies, sars-cov-2 infection